Consolidated Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Assets
Loans receivable, net of deferred origination and other fees	$ 63,672,278	$ 65,405,731
Interest and other fees receivable on loans	1,618,826	1,521,033
Cash	201,363	178,012
Cash – restricted	21,769	23,750
Other assets	119,642	62,080
Right-of-use asset – operating lease, net	140,836	154,039
Deferred financing costs, net	12,706	16,171
Total assets	65,787,420	67,360,816
Liabilities:
Line of credit	14,825,735	16,427,874
Senior secured notes (net of deferred financing costs of $78,214 and $96,985, respectively)	5,921,786	5,903,015
Accounts payable and accrued expenses	194,801	232,236
Operating lease liability	153,571	167,119
Loan holdback	50,000	50,000
Dividends payable	1,315,445	1,315,445
Total liabilities	22,461,338	24,095,689
Commitments and contingencies
Stockholders’ equity:
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued and outstanding
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 outstanding	11,757	11,757
Additional paid-in capital	45,565,207	45,561,941
Less: Treasury stock, at cost – 318,407 shares	(1,070,406)	(1,070,406)
Accumulated deficit	(1,180,476)	(1,238,165)
Total stockholders’ equity	43,326,082	43,265,127
Total liabilities and stockholders’ equity	$ 65,787,420	$ 67,360,816